Posted by AGORACOM-JC
at 3:46 PM on Friday, March 1st, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) Converting irrigated farmland to
greenhouse-equipped farmland. Bougainville does not “touch the plantâ€
and only provides agricultural infrastructure as a landlord for
licensed marijuana growers. Click here for more info.
BOG:CSE —————————————
Why The Cannabis Sector Has More Room to Run
Positive developments are palpable in the marijuana industry.
Be it acquisitions, expansion into industries like food, beverage, tobacco and cosmetics or legalization, things are increasingly falling into place for marijuana.
From Sanghamitra Saha: Positive developments are palpable in the marijuana industry. Be it acquisitions, expansion into industries like food, beverage, tobacco and cosmetics or legalization, things are increasingly falling into place for marijuana. ETFMG Alternative Harvest ETF (MJ – Free Report) is up 48.7% this year and appears to have more room to run.
Will FDA Regulate CBD in April?
There is growing demand for uses of CBD, a non-psychoactive
ingredient in cannabis, in food, drinks and cosmetics. Naturally,
companies selling food and drinks with CBD want FDA regulation for the industry. Though the U.S. FDA has forbidden companies from infusing CBD in food, many drink companies have announced plans to use it.
Congress legalized hemp products,
including most CBD, in December in the 2018 Farm Bill. The FDA now has
to set new rules for the industry. Amid ongoing legal uncertainty, which
is causing quite an upheaval for the rising industry, FDA Commissioner
Scott Gottlieb’s latest comment brought good news for the industry. He
said “public meetings will be held sometime in April to hear from
relevant parties on how best to regulate CBD derived from hemp,†per
MarketWatch.
The joining of Martha Stewart came with the deal between Sequential Brands Group Inc. (SQBG – Free Report)
(up 40% on Feb 28) and Canopy Growth (up 3.6% on the day). Sequential
Brands, which is a licensing and brand management company, owns
Stewart’s media company Living Omnimedia since Dec 2015.Substantial Growth Prospect in Hemp-CBD Market
The Hemp Business Journal estimates that sales in the hemp-CBD market
will shoot up from $390 million in 2018, to about $1.3 billion by 2022.
As U.S. cannabis companies are still under regulatory prohibitions,
Canadian operators are looking for ways to expand their reach by mergers
and acquisitions, per the source.
And the hemp-CBD market offers lucrative opportunities for this. This
is because the 2018 Farm Bill subjects hemp and its derivatives to
agricultural products category rather than controlled substances.
Canopy Growth has plans to invest between $100 million and $150
million in a hemp industrial park in New York state, per Reuters.
Meanwhile, Canada’s Tilray(TLRY – Free Report) is working with Authentic Brands Group on
a line of consumer products. Tilray announced an acquisition of the
world’s largest hemp food maker Manitoba Harvest for about $318 million
in February. Arcadia Biosciences Inc. (RKDA – Free Report)
– which normally develops food ingredients from wheat and soybeans –
saw its shares jumping 49% on Feb 28 after it divulged plans to foray into the hemp industry (read: Top ETF Stories of February).
Tags: Marijuana, stocks, tsx, weed Posted in Bougainville Ventures | Comments Off on Bougainville Ventures Inc $BOG.ca – Why The Cannabis Sector Has More Room to Run $CROP.ca $VP.ca NF.ca $MCOA
Posted by AGORACOM-JC
at 12:33 PM on Monday, February 25th, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) Converting irrigated farmland to
greenhouse-equipped farmland. Bougainville does not “touch the plantâ€
and only provides agricultural infrastructure as a landlord for
licensed marijuana growers. Click here for more info.
BOG:CSE —————————————
Nearly 1 in 6 Canadians Have Used Marijuana Since Recreational Pot Was Legalized
New data from Statistics Canada offers an inside look at cannabis consumption rates based on province, gender, and age.
The sky seems to be the limit for the legal marijuana industry.
According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue.
More immediately, a co-authored report from Arcview Market Research and BDS Analytics has called for 38% global sales growth in 2019 to $16.9 billion.
Sean Williams Feb 23, 2019 at 10:51AM
The sky seems to be the limit for the legal marijuana industry.
According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue.
More immediately, a co-authored report from Arcview Market Research and
BDS Analytics has called for 38% global sales growth in 2019 to $16.9
billion. No matter how you analyze the data, that’s a lot of green to go
around; and it’s a big reason why pot stocks have been virtually
unstoppable since the year began.
Although the United States would represent the largest cannabis
market in the world by sales if it were legalized at the federal level,
it’s our northerly neighbor Canada that’s leading the charge on
marijuana reform. Having become the first industrialized country in the world,
and only second overall behind Uruguay, to legalize adult-use pot in
October, Canada looks to be on track for an estimated $5.9 billion in
annual sales by 2022.
Image source: Getty Images.
An inside look at the average Canadian cannabis user
But just how quickly are Canadians adapting to this legalized
environment? For that answer, I turn to Statistics Canada, the national
statistics office that gathers information on Canada’s economy,
environment, and society.
Recently (as of Feb. 21, 2019), Statistics Canada released self-reported data
on consumers’ use of cannabis over the past three months. As a
refresher, marijuana legalization occurred roughly four months ago,
although the first month was a supply-side disaster. That means the past
three months of use should give us a really good idea of what the
typical Canadian consumer looks like.
According to the data, which Statistics Canada will continue to
update, 15.4% of all citizens, or nearly 1 out of 6 Canadians, have used
cannabis over the past three months. As you can imagine, usage
statistics tend to vary by region, gender, and age. For instance, Quebec
had the lowest percentage of people using marijuana over the past three
months (13.6%), while the lesser-populated Nova Scotia had the highest
percentage by far at 21.6%. Newfoundland and Labrador and New Brunswick
were also significantly above the national self-reported average in
three-month use rates.
In terms of gender, men were significantly more likely than women (19.4% vs. 11.3%) to have consumed cannabis recently.
Finally, as you might expect, pot use over the past three months was
considerably higher among younger people than older folks. Overall,
27.4% of Canadians aged 15 to 24 and 23.2% of those aged 25 to 34 used
cannabis over the past three months. Meanwhile, just 5.2% of seniors
aged 65 and up and 10.4% of Canadians aged 55 to 64 used weed recently.
Even though the older generation has more disposable income, it’s these
younger adults that are the future of the legal weed industry.
Image source: Getty Images.
Cannabis consumption rates are likely to rise — here’s why
Although there were no major surprises here, there are some relatively interesting takeaways to be made.
For example, an average use rate of just 15.4% might seem rather low,
but it’s not factoring in two pretty important catalysts. First,
there’s the fact that marijuana growers are still in the early stages of
ramping up their production. Aurora Cannabis (NYSE:ACB), which is my selection to lead the country with 700,000 kilograms of peak annual production,
is only producing at an annual run rate of 120,000 kilos right now. By
the end of the current calendar quarter, Aurora Cannabis should be
yielding more than 150,000 kilos annually, but it’s going to take
perhaps 12 to 24 more months before Aurora is operating on all
cylinders. When consumers have access to ample demand and the per-gram
price for dried cannabis flower comes down a bit, we’re liable to see
usage rates increase.
The second catalyst is the expected legalization of new consumption
options by this fall. When the Cannabis Act was signed into law last
June, and legal product sales commenced on Oct. 17, 2018, it only
included dried flower, cannabis oil, and sprays. Alternative products
such as edibles and cannabis-infused beverages aren’t yet legal.
That, however, is expected to change by no later than Oct. 17, 2019,
according to an outline presented by Health Canada. Edibles and infused
beverages containing cannabidiol (CBD), the nonpsychoactive cannabinoid
best known for its medical benefits, are expected to be especially
important in luring in new users.
The provincial-use data is also interesting in that it highlights one potential under-the-radar grower: OrganiGram Holdings (NASDAQOTH:OGRMF). The New Brunswick-based OrganiGram is the only Atlantic grower expected to yield more than 100,000 kilograms
per year when at full production capacity. Its geographic location
gives it competitive advantages in New Brunswick, Nova Scotia, and
Newfoundland and Labrador. Sure, these are far less populated regions
than, say, Ontario or Quebec, but it nevertheless allows OrganiGram a
foothold in these potentially higher-use provinces and territories.
OrganiGram was already a value stock among its peers, but it’s now that
much more intriguing following the release of this data.
Image source: Getty Images.
I believe this data also demonstrates the scope of opportunity awaiting Shopify (NYSE:SHOP) and its e-commerce platform. A number of large growers and provinces, including Ontario,
have chosen to utilize Shopify’s sales platform for online and
brick-and-mortar sales. Aside from simply being the sales platform of
choice, Shopify offers marijuana companies purchasing data on consumers
for pretty much the first time ever. With this being a cash-dominated
industry, it’s been virtually impossible for growers and retailers to
understand their customer base. With Shopify, this is going to change,
and both producers and retailers will be able to more directly target
consumers.
Ultimately, the legal weed industry is still in its infancy in
Canada. That means we’re liable to see this data shift as Health Canada
adjusts the boundaries of what’s legal and growers and retailers come to
better understand their customers.
Posted by AGORACOM-JC
at 12:38 PM on Friday, February 22nd, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Cannabis edibles, plant proteins and other food trends to watch for in 2019
Canada is high on cannabis edibles
Cannabis will soon be a major driver in the food and beverage category.
This year should see edible products incorporated into Bill
C-45 (the Cannabis Act), opening up opportunities for health foods and
supplements, snack foods, packaged meals, restaurants and tourism.
A recent Deloitte report found that 58 per cent of current Canadian cannabis users intend to consume edibles once they’re legalized.
Food continues to find its way into the consciousness of Canadians.
It’s in our news feed, on our television screens and, more and more,
part of our day-to-day conversations. The challenge is to separate the
fact from the fiction, the ephemeral from the soon-to-be everyday. The
University of Guelph’s newest Food Focus Trends Report highlights six key trends likely to be front and centre this year.
Flexitarians on the rise
While vegans and vegetarians get all the attention, the flexitarians
are rapidly growing in number — and in clout. A flexitarian is someone
who is eating less meat rather than giving it up entirely.
Almost 85 per cent of Canadians claim to eat at least one vegetarian
meal per month, with nearly 50 per cent saying they do so at least once a
week. Despite only seven to eight per cent of Canadians identifying as
vegetarian or vegan, the conscious consumption of flexitarians will
likely have a profound impact on the quantity and types of meat we eat
as well as spurring the growth of protein alternatives.
By choosing to eat less meat, consumers are likely to indulge in more premium cuts while sacrificing staples like ground beef.
Plant-based proteins are also sure to grow in popularity, as are
those from previously taboo sources, such as insects. Canada’s new Food Guide also recommends an increased focus on plant-based foods.
Should Canada’s meat industry be concerned? Possibly, but increased
international demand should keep overall prices in our country steady
for the foreseeable future and population growth here will also continue
to increase the total demand for meat.
Easing fears about gene-editing
If comic books and horror movies have taught the average Canadian
anything, it’s that nothing good ever comes from playing with genes.
Unfortunately, fiction can sometimes be more believable than facts.
When it comes to agriculture, gene editing increases yields, develops
tolerances to things like drought or pests, removes allergens (to make
gluten-free wheat, for example) and enhances nutritional quality.
And the biggest benefit
may be for the world’s poor. Basically, gene editing is doing what
animal and plant breeders have been doing for hundreds and hundreds of
years, only in a way that’s much faster, much cheaper and much more
specific.
The only challenge? Reducing unfounded fears and communicating the
incredible potential of genetically modified crops and foods in a way
that Canadians can fully embrace.
So shouldn’t we all be behind the bee? It’s not that simple.
While they are essential for some crops, other crops rely on methods
of pest control that are associated with the decline of pollinators.
As we’ve seen with the neonicotinoids debate, striking a delicate
balance between the needs of farmers and the protection of pollinators
is an ongoing challenge and a goal that will not be easily achieved.
Canada is high on cannabis edibles
Cannabis will soon be a major driver in the food and beverage
category. This year should see edible products incorporated into Bill
C-45 (the Cannabis Act), opening up opportunities for health foods and
supplements, snack foods, packaged meals, restaurants and tourism.
A recent Deloitte report found that 58 per cent of current Canadian cannabis users intend to consume edibles once they’re legalized.
But these highs do have some potential lows — work will need to be
done to ensure proper dosing and to prevent unintended secondary
consumption by children and pets.
As well, the path to market for cannabis products in Canada goes
through three different pieces of legislation: the Cannabis Act, the
Controlled Drugs and Substances Act and the Food and Drugs Act.
In addition, products for medical consumers must also meet the Access
to Cannabis for Medical Purposes Regulations that are included in the
Controlled Drugs and Substances Act. But with the total market estimated
at more than $7 billion (on par with Canada’s wine industry), the
future is nonetheless bright for cannabis companies.
Prospering in a time of protectionism
The whirlwind of trade deals and disputes in the past few years has
left many Canadians reeling. While there has been much hand-wringing
over inter-provincial barriers, NAFTA/USMCA and new agreements with
Europe and the Pacific Rim, freer trade in food has actually provided
Canadian farmers with markets that are hungry for our products.
Plus, Canadian consumers have benefited and now enjoy a wider range of affordable food products.
The one downside? Our regulated dairy industry, along with other
supply managed commodities, has ceded nearly 10 per cent of its market
through recent trade deals.
This will not only be painful for the dairy sector, but it isn’t
likely to result in lower prices for Canadians — although we will
probably see a broader array of cheeses and other dairy products.
Overall, though, trade has been good for Canada and will continue to be
for the foreseeable future.
Growing divide between food & farms
Farms may feed people, but they have very little to do with the price you pay for food.
Fluctuating prices of agricultural commodities like corn, wheat or
soybeans often fuel news stories but the reality is the increases in
food prices Canadians have seen over the years have been relatively
consistent.
Put simply, food and farm prices are not the same and the relationship between the two continues to weaken. Today, the farmers’ share
of the food dollar is around 20 per cent — higher for less processed
foods (nearly 50 per cent for eggs) and lower for more processed foods
(two per cent for corn, which is used as a sweetener in manufactured
food products).
While the effect of low commodity prices may be felt in farming
regions and associated industries, it has little impact on Canadians
when they’re checking off their grocery lists — and that isn’t expected
to change in 2019.
Posted by AGORACOM-JC
at 10:12 AM on Friday, February 8th, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) Converting irrigated farmland to
greenhouse-equipped farmland. Bougainville does not “touch the plantâ€
and only provides agricultural infrastructure as a landlord for
licensed marijuana growers. Click here for more info.
BOG:CSE —————————————
POT Ticker Generates Frenzy As WHO Softens Stance On Marijuana
Little illustrates the mania for cannabis investments better than the unprecedented demand over the stock symbol POT.
But new recommendations from the World Health Organization suggest some of that frenzy may not be unwarranted.
Tiny Vancouver-based cannabis company Weekend Unlimited saw its stock
gain as much as 148% Feb. 1 after winning out over 40 other companies
in the first-ever lottery for a stock ticker held by Canadian exchanges.
Weekend Unlimited, which previously traded under YOLO, short for “you
only live once,” wasn’t exactly lacking a memorable ticker before it won
the POT ticker.
In a weird twist, the YOLO symbol may find new life in another
pot-related security, as the AdvisorShares Pure Cannabis ETF has filed
to trade on the New York Stock Exchange under YOLO.
In more serious news, the WHO is recommending that cannabis and its
resin be removed from Schedule IV, the most restrictive category of a
1961 drug convention that governs international treaties. The WHO is
also moving to clarify that CBD containing less than 0.2% THC is not
under international control at all.
If adopted, these recommendations would recognize changing attitudes
toward the drug and its medical properties, potentially encouraging
fence-sitting politicians to speed up the pace of legalization. They
could also be a “catalyst for Big Pharma to further assess the global
medical cannabis opportunity,” according to BMO analyst Tamy Chen.
Advertising Challenges
“The treaty’s recommended cannabis rescheduling provides countries
additional political cover to re-examine their current state on
cannabis, given it serves as the regulatory framework for many,” writes
Bloomberg Intelligence analyst Kenneth Shea.
The proposals will now go to the United Nations’ Commission on
Narcotic Drugs, whose 53 member nations will have the chance to vote on
them, likely in March.
POT hype and WHO recommendations aren’t making it any easier to
advertise cannabis brands, at least not yet. Earlier this month, CBS
declined to air a commercial touting the benefits of medical marijuana
during the Super Bowl and Facebook (FB) has booted some pot sellers off Instagram, Bloomberg’s Craig Giammona reported last week.
The restrictions are even tighter in Canada, where nearly all forms of marketing and branding are prohibited.
Canadian Supply
The Canadian government reported that total cannabis sales in
December were up 4% from the month before, a muted gain given that
November sales marked a 42% decline in per-day recreational pot sales
from October, when legalization took effect.
The fact that total inventory continues to grow, hitting nearly two
months’ worth of dried pot and five months’ of cannabis oil at the end
of December, indicates that Canada’s ongoing supply shortage is more a
function of supply-chain problems than a lack of product, according to
Eight Capital analyst Graeme Kreindler.
“The process of getting products from vault to shelf remains a key
step in alleviating supply issues in the Canadian market,” Kreindler
said.
Edibles Question
The ongoing shortages, whatever their root cause, have raised
concerns among some in the industry that it won’t be ready to meet
demand for edibles and concentrates, which were expected to join dried
flower and oils on store shelves by October of this year. However,
Justin Trudeau’s pot czar told Bloomberg’s Josh Wingrove last week that
sales may lag regulations, citing the 17-week gap between the federal
pot law passing last June and the formal market opening in October.
According to Keith Merker, CEO of WeedMD, “It’s classic cannabis
industry stuff; you’re operating in this mist of uncertainty and trying
to make business decisions that are appropriate.”
The lack of clarity isn’t deterring big U.S. funds from sniffing
around the industry. Funds with $100 billion or more in assets under
management are exploring lending to Canadian cannabis companies as a way
to gain expertise in the burgeoning market ahead of potential
legalization.
The idea is to provide first-lien loans, which are first to be repaid
when a company fails, to mid-tier pot firms, according to Cormark
Securities’ Alfred Avanessy. This would open up a whole new world of
financing to the industry, which has largely relied on equity raises and
convertible debt to date.
Tags: Marijuana, weed Posted in All Recent Posts, Bougainville Ventures | Comments Off on Bougainville Ventures Inc $BOG.ca – #POT Ticker Generates Frenzy As WHO Softens Stance On Marijuana $CROP.ca $VP.ca NF.ca $MCOA
Posted by AGORACOM-JC
at 12:26 PM on Thursday, February 7th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Canada’s top marijuana enforcer stands by Liberals’ new pot policy
A former police chief and narcotics enforcement officer, federal Minister of Border Security and Organized Crime Reduction Bill Blair is convinced Canada has done the right thing with its new marijuana decriminalization and regularization laws.
Martin C. Barry
As the federal minister responsible for the implementation and
enforcement of Canada’s new marijuana legalization and regularization
laws, there’s no mistaking the fact Bill Blair stands one hundred per
cent behind the Trudeau Liberal government’s groundbreaking policy.
If anybody might be in a position to question the government’s
stance, it could easily be Blair. The veteran policeman and former chief
of the Toronto Police Service spent years fighting on the front lines
against drug-related crime as a narcotics squad officer.
Former narcotics cop
“As a police officer for 40 years, I was involved in drug
enforcement,†Blair, who is Minister of Border Security and Organized
Crime Reduction, said in an interview with Newsfirst Multimedia while on
a ministerial stopover in Montreal.
As chair of the Canadian Association of Chiefs of Police’s Organized
Crime Committee, he said he was “well aware of the impact that illegal
drug trafficking as controlled by organized crime was having in all of
our communities.â€
Drugs and violence linked
While noting that the link between organized crime and illegal drug
trafficking had a lot do with an escalation of violence in Canadian
cities these past few decades, Blair also pointed out that organized
crime was earning billions of dollars in profits each year being the
sole purveyors of a range of illegal substances that included marijuana.
Since the only means of controlling the situation available to
society was criminal sanction, young people got swept up in the overall
enforcement of the country’s drug laws, “which was disproportionate,â€
added Blair, “and was actually causing in many cases more harm. We
wanted to discourage their use of the drug. But we also did not want to
saddle that child with a criminal record for the rest of their life.â€
Approached by Trudeau
According to Blair, all of this transpired long before he was asked
by Justin Trudeau to run in the suburban Toronto riding of Scarborough
Southwest in the October 2015 election. Blair and the future Prime
Minister discussed the possibility of radically changing Canada’s
cannabis laws.
“We talked about Canada’s control of cannabis. And he said ‘What do
you think of legalizing it?’ And I said if we lift the criminal
prohibition it gives the opportunity to get the situation back under
control. Because currently the situation we were in was we had the
highest rates of use among our kids in the world. And this is a
dangerous drug for children. This is a drug that can have very serious
implications for children.â€
One third were breaking law
Leading up to the changes last October by the Liberal government to
the country’s longstanding prohibition on cannabis, more than a third of
Canada’s population had been breaking the law, Blair added. As such,
“we began the process of looking at how do we reduce the harm of this
drug.
“Some people say to me, ‘Well you’ve legalized cannabis.’ And I say
no – we’ve regulated the daylights out of it. We’ve brought in all sorts
of new rules – enforceable, proportionate, sensible rules – that
control every aspect of its production, its sale and its consumption.
Says no to other drugs
“Whereas before we had only one tool and it was like a sledgehammer
and we were trying to drive a nail. And no one wanted to swing the
sledgehammer. But now we have the right suite of tools to control the
system. And I believe it’ll result in a healthy situation for our
children and a safer situation for our communities.â€
Blair insisted that neither he nor the Liberal government would ever
consider going down the same route with other street drugs as it has
done with marijuana. “Cannabis is not a drug that kills people,†he
said.
“But unfortunately with other more serious drugs which are deadly –
the opioid crisis, for example, crystal methamphetamine, which is
ravishing some of our prairie and northern communities – those drugs
represent such a significant risk. And we don’t have a system of
regulated production and control.
Meth and fentanyl out
“There is no alternative. We can go to a Health Canada-regulated
production facility for marijuana, for cannabis. But we’re not going to
create a similar thing for crystal methamphetamine. So there will be no
other source other than the criminal source.†For drugs like
methamphetamine and fentanyl, Blair said an important of the approach
for dealing with them is to “interdict the supply to keep those drugs
out of our country. We need to be very effective at restricting the
supply. But we also have an enormous amount of work to do – and we have
embarked as a government on this – to reduce the demand for those drugs.
And that’s to prevent people from beginning to use them in the first
place.â€
Tags: Marijuana, tsx, weed Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Canada’s top marijuana enforcer stands by Liberals’ new pot policy $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 8:47 AM on Tuesday, February 5th, 2019
Announced that its wholly owned subsidiary hempSMART™ attended special promotional events for its CBD infused product line during Super Bowl LIII this past weekend
The events included Ray Lewis’s “Ray of Hope†Foundation’s Gold Jacket for a Purpose event, and a special presentation at the Ice Box Club in Atlanta.
ESCONDIDO, Calif., Feb. 05, 2019 – via NetworkWire – MARIJUANA COMPANY OF AMERICA INC.(“MCOA†or the “Companyâ€) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary hempSMART™ attended special promotional events for its CBD infused product line during Super Bowl LIII this past weekend. The events included Ray Lewis’s “Ray of Hope†Foundation’s Gold Jacket for a Purpose event, and a special presentation at the Ice Box Club in Atlanta.
A number of professional athletes, NFL coaches, actors, musicians and
other persons of interest attended the events and were given samples of
the Company’s hempSMART branded products, including hempSMART™ Brain
and hempSMART™ Pain Cream.
Some of the notable attendees were Ray Lewis, Deion Sanders, Andre
Reed, Marshawn Lynch, Tyreek Hill, Larry Fitzgerald, Terrell Owens,
Candance Parker, Jon Stewart, Andre Reed, Quincy Jones, Malcolm Jenkins,
Von Miller, Brandon Marshall, Eddie George, Adrian Peterson, Maroon 5,
and the Backstreet Boys.
CEO of MCOA, Donald Steinberg, stated, “Attending the Super Bowl LIII
events this past weekend provided a great opportunity for well-known
professional athletes and celebrities to discover how amazing and
beneficial our products can be for them. MCOA anticipates that the
Company will receive added exposure and an increase in brand awareness
by exposing well-known individuals to our products.â€
MCOA is looking forward to continuing to obtain brand exposure
through its involvement at a pre-Oscar event later this month, where the
Company expects to give out hempSMART samples to several Hollywood
stars.
About Marijuana Company of America, Inc. MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products containing
CBD derived from industrial hemp are not marketed or sold based upon
claims that their use is safe and effective treatment for any medical
condition as drugs or dietary supplements subject to the FDA’s
jurisdiction.
Forward Looking Statements This news
release contains “forward-looking statements” which are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities and words such as “anticipate”,
“seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or
similar phrases may be deemed “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition, and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
For more information, please visit the Company’s websites at:
Tags: Marijuana, otcbb, weed Posted in Marijuana Company of America | Comments Off on Marijuana Company of America’s $MCOA hempSMART CBD Products Promoted at Super Bowl LIII $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 2:55 PM on Monday, February 4th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
New Cannabis Products Which Could Disrupt the Industry in 2019
If there is one large-scale category of cannabis product which is likely to emerge in 2019, it is edibles.
When Canada moved to legalize recreational marijuana usage among adults, it did not include regulations for edibles and other products which might be confused for non-cannabis alternatives
The cannabis industry enjoyed tremendous investor enthusiasm in 2018,
fueled in large part by major developments which seemed to open up the
space for new opportunities. Canadian legalization of recreational
marijuana use, the continued adoption of legal medical or recreational
cannabis in more states across the U.S., and high-profile achievements
from some of the industry’s emerging top contenders all fueled interest.
In spite of the fact that cannabis stocks overall failed to perform up
to expectations last year, 2019 has already revealed continued anticipation regarding this growing industry.
If cannabis stocks are to thrive going forward,
it’s likely that many companies will have some growing up to do.
Overextended balance sheets will need to be strengthened, highly
speculative mergers and acquisitions must be kept in check, and
quarterly figures will have to confirm that there is good reason for the
hype surrounding these companies.
One way that up-and-coming marijuana businesses can bolster their fortunes in 2019 is through the release of new cannabis-based products.
While it’s true that there has already been a flood of new marijuana
products to the market, it’s likely that only a few will emerge as
winners capable of driving sales and firming up particular companies’
dominant status in this fledgling market. Below, we’ll take a look at
some new cannabis products which may be able to change the game in this
way.
Edibles
If there is one large-scale category of cannabis product which is
likely to emerge in 2019, it is edibles. When Canada moved to legalize
recreational marijuana usage among adults, it did not include
regulations for edibles and other products which might be confused for
non-cannabis alternatives. The Canadian government allowed itself a
one-year window from the initial legalization date of October 17, 2018
to sort out regulations for edibles products. In the meantime, Canadian
marijuana companies have gotten a head start on developing new cannabis
edibles for retail sale, even as retailers are giving away product that
they are not yet allowed to sell. A recent survey indicated that about a quarter of Canadian cannabis customers had received a free edible in the last month.
When Canadian edibles become legal for retail sale on or before
October 17, 2019, expect a rush to get these products into retail shops.
Edibles alone could become a billion-dollar industry in the years to
come.
Cannabis Beverages
One of the biggest cannabis headlines of 2018 reported on news that Constellation Brands (STZ), the beverage company behind Corona and Modelo brand beers, had partnered with Canopy Growth Corp. (CGC),
the largest cannabis producer in Canada. The alignment of a major
cannabis company with a top producer of alcoholic beverages has many
analysts and investors speculating that there could be joint product
launches in the near future. Indeed, other pairs of companies have also
matched up in recent months as well: Molson Coors announced a partnership with Canadian producer HEXO also.
It’s unlikely that any existing products from companies like
Constellation and Molson will change because of these partnerships.
However, expect a THC-infused beverage market to crop up as a
subcategory of the larger edibles space. These products could include
THC- or cannabidiol (CBD)-infused juices, waters and seltzers or
coffees. CBD products may be marketed as “health” drinks aimed at
reducing anxiety and inflammation without generating a “high” feeling in
the same way that THC does.
Cannabidiol Products
Before 2018 was finished, CBD had already begun to make its way into
all manner of products for sale. Although cannabis includes dozens of
chemical components, CBD has emerged early on as a popular one for
extraction and subsequent inclusion in drinks, vaping products, bath
bombs and more. CBD has been marketed as a product with wide-ranging
health benefits which can help to cure everything from pain to insomnia.
While it’s difficult to say exactly how accurate this claim is, it has
nonetheless been sufficient to generate widespread interest in CBD, even
among consumers not interested in the traditional “high” associated
with cannabis. Expect a continued proliferation of CBD-based products in
the months to come. Beauty and skin care products are among the most
popular of these new offerings.
Cannabidiol has also made its way into drug treatments developed in
the medical marijuana space. Indeed, the first FDA-approved
cannabis-based drug makes use of a pharmaceutical CBD oil. Companies
like GW Pharmaceuticals (GWPH) and Cara Therapeutics (CARA)
are rushing to develop and test new CBD-based drug treatments. While
this process takes a much longer time than the development of retail
CBD-based products, it has the potential for tremendous industry-wide
staying power, not to mention the benefit of providing more evidence of
the efficacy of medical marijuana on a broader level.
Posted by AGORACOM-JC
at 2:23 PM on Wednesday, January 23rd, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Canadians spent $41 million on weed in first month after legalization
Canadians bought $54 million Canadian ($41 million) of marijuana from stores in the first full month after sales were legalized, some of the clearest evidence yet of the market’s potential.
Canada’s figure for November released Wednesday follows an earlier estimate that sales were $43 million Canadian in the first two weeks following legalization on Oct. 17.
The Ottawa-based agency added cannabis to standard monthly reports on retail sales as part of wider effort to update the nation’s economic accounts.
“Retail figures will vary as new stores continue to come on line and
the marketplace continues to evolve,†the agency’s report said.
The potential for a market worth between $5.5 billion Canadian and
$10 billion Canadian a year created a boom in the value of producers
such as Canopy Growth Corp. and Aurora Cannabis Inc. Canada became the
first Group of Seven nation to legalize the drug as Prime Minister
Justin Trudeau said prohibition was a failed system that gave profits to
criminal gangs and allowed rampant youth consumption.
Tags: Marijuana, tsx-v, weed Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Canadians spent $41 million on weed in first month after legalization $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 3:35 PM on Friday, January 18th, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food,
beverage and science companies to provide safe standardized cannabinoid
infused raw inputs for large scale GMP manufacturing of products
Announced Creation of “1017†Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line
THE OPPORTUNITY
Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
